Published in J Diabetes on December 01, 2012
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes (2015) 0.92
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes. J Clin Med (2014) 0.76
Practical combination therapy based on pathophysiology of type 2 diabetes. Diabetes Metab Syndr Obes (2016) 0.75
Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. Int J Endocrinol (2016) 0.75
Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients. J Res Pharm Pract (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Epidemic obesity and type 2 diabetes in Asia. Lancet (2006) 9.54
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med (1995) 6.51
Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther (2002) 1.80
Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med (1997) 1.69
The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study. Int J Clin Pract (2008) 1.40
Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr (2007) 1.28
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care (1993) 1.17
A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf (1999) 1.15
Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabete Metab (1991) 1.05
Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes. Diabet Med (2005) 1.01
Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Curr Med Res Opin (2004) 0.98
Steady-state pharmacokinetics of a novel extended-release metformin formulation. Clin Pharmacokinet (2005) 0.96
Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes Obes Metab (2009) 0.96
Metformin in the digestive tract. Diabetes Res Clin Pract (1988) 0.95
Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies. Diabetes Obes Metab (2005) 0.93
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clin Ther (2003) 0.87
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care (1993) 0.86
Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. J Clin Pharmacol (2001) 0.82
Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective. Diabetes Res Clin Pract (2006) 0.82
Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations. Eur J Gastroenterol Hepatol (1999) 0.80
The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control. J Pak Med Assoc (2000) 0.78
Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus. J Gen Virol (2012) 1.12
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med (2002) 0.98
Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin. Curr Eye Res (2006) 0.96
Small Rice Bowl-Based Meal Plan versus Food Exchange-Based Meal Plan for Weight, Glucose and Lipid Control in Obese Type 2 Diabetic Patients. Korean Diabetes J (2010) 0.94
Effectiveness of topical infliximab in a mouse model of experimental dry eye. Cornea (2012) 0.88
Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res (2011) 0.86
Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. Curr Eye Res (2014) 0.86
Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes. Diabetes Metab J (2012) 0.83
Adsorption and conformation behavior of biotinylated fibronectin on streptavidin-modified TiO(X) surfaces studied by SPR and AFM. Langmuir (2011) 0.81
The effects of small sized rice bowl on carbohydrate intake and dietary patterns in women with type 2 diabetes. Korean Diabetes J (2010) 0.81
Hypocholesterolemic property of Yucca schidigera and Quillaja saponaria extracts in human body. Arch Pharm Res (2003) 0.81
Expression of CXCL9, -10, and -11 in the aqueous humor of patients with herpetic endotheliitis. Cornea (2012) 0.80
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice. Diabetes Res Clin Pract (2012) 0.79
Occurrence of ectoparasiticides in Australian beef cattle feedlot wastes. Environ Pollut (2013) 0.79
DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, in type-2 diabetes mellitus patients inadequately controlled by metformin and other oral antidiabetic agents. J Complement Integr Med (2016) 0.78
Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye. Invest Ophthalmol Vis Sci (2013) 0.78
Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate. J Cosmet Dermatol (2013) 0.78
Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia--link to renal status, glycemic control and vascular inflammation. Diabetes Res Clin Pract (2011) 0.78
Radical trapping in glycogen storage disease 1a. Eur J Pediatr (2002) 0.77
Application of umbilical cord serum eyedrops after laser epithelial keratomileusis. Acta Ophthalmol (2012) 0.77
Quantification of bacterial indicators and zoonotic pathogens in dairy wastewater ponds. Appl Environ Microbiol (2012) 0.75
Wasp sting of the cornea: a case treated with amniotic membrane transplantation. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Sequential injection analysis system for on-line monitoring of l-cysteine concentration in biological processes. Talanta (2005) 0.75
Flow injection analysis system for monitoring of succinic acid in biotechnological processes. Talanta (2005) 0.75
Safety and efficacy in early insulin initiation as comprehensive therapy for patients with type 2 diabetes in primary health care centers. Acta Med Indones (2015) 0.75
Streptavidin-coated TiO2 surfaces are biologically inert: protein adsorption and osteoblast adhesion studies. J Biomed Mater Res A (2011) 0.75
Bilateral iris metastasis from endometrial carcinoma. Jpn J Ophthalmol (2007) 0.75
Effects of Elastic Band Resistance Training on Glucose Control, Body Composition, and Physical Function in Women With Short- vs. Long-Duration Type-2 Diabetes. J Strength Cond Res (2016) 0.75